Bayer AG\u00a0 is going to sell the part of its business\u00a0 in biotechnologies and productions of cotton\u00a0 spheres. It is concerned the Crop Science\u00a0 subsidiary Company. According to Liman Kondon, the company chairman, this industry sphere is money-making.\u00a0 There is no reason in\u00a0 finding buyers\u00a0 to Buyer.<\/p>\n
The decision was concluded by a pressure of the Anti-Monopoly authorities.\u00a0 For the time being, they are conducting the agreement between the German Corporation and Monsanto Company. Cooperation agreement which was signed some days ago is estimated at 66 billion dollars.\u00a0 With the purpose of the close transaction to the end of a year, Buyer has produced bonds in the amount of 4 milliard euros. The next step is separate details coordination with monitoring authorities.<\/p>\n
Bayer AG shareholders are not ready\u00a0 to estimate the previous cost of Crop Science Company at the moment. The main company\u00a0 invests\u00a0 in this business development about 10% of its income every year. It is more than 850 million euros. The Bayer Crop Science\u00a0 posses the third place in the agricultural sphere.<\/p>\n